ZA988920B - Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome - Google Patents

Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome

Info

Publication number
ZA988920B
ZA988920B ZA988920A ZA988920A ZA988920B ZA 988920 B ZA988920 B ZA 988920B ZA 988920 A ZA988920 A ZA 988920A ZA 988920 A ZA988920 A ZA 988920A ZA 988920 B ZA988920 B ZA 988920B
Authority
ZA
South Africa
Prior art keywords
treatment
pharmaceutical composition
inflammatory bowel
bowel disease
bowel syndrome
Prior art date
Application number
ZA988920A
Other languages
English (en)
Inventor
John Rhodes
Brian Kenneth Evans
Original Assignee
John Rhodes
Brian Kenneth Evans
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Rhodes, Brian Kenneth Evans filed Critical John Rhodes
Publication of ZA988920B publication Critical patent/ZA988920B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA988920A 1997-09-30 1998-09-30 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome ZA988920B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9720797.1A GB9720797D0 (en) 1997-09-30 1997-09-30 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome

Publications (1)

Publication Number Publication Date
ZA988920B true ZA988920B (en) 1999-06-09

Family

ID=10819864

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA988920A ZA988920B (en) 1997-09-30 1998-09-30 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome

Country Status (7)

Country Link
EP (1) EP1019038A1 (xx)
JP (1) JP2001517697A (xx)
AU (1) AU9273198A (xx)
CA (1) CA2304516A1 (xx)
GB (1) GB9720797D0 (xx)
WO (1) WO1999016436A1 (xx)
ZA (1) ZA988920B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ299726B6 (cs) * 1999-11-01 2008-11-05 Lécivo pro lécení zácpy a syndromu dráždivého tracníku
US7081475B2 (en) 2001-09-14 2006-07-25 Prolx Pharmaceuticals Corp. Wortmannin analogs and methods of using same
EP1690557A1 (en) * 2005-02-11 2006-08-16 NOLabs AB Device for treatment of rectal disorders, and manufacturing process for the same
WO2006084913A2 (en) * 2005-02-11 2006-08-17 Nolabs Ab Device for treatment of rectal disorders, and manufacturing process for the same, involving nitric oxide
AU2012203798B2 (en) * 2005-08-12 2013-11-07 Northrop Grumman Systems Corporation O-nitro compounds, pharmaceutical compositons thereof and uses thereof
US7507842B2 (en) 2005-08-12 2009-03-24 Radiorx, Inc. Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
US20070135380A1 (en) 2005-08-12 2007-06-14 Radiorx, Inc. O-nitro compounds, pharmaceutical compositions thereof and uses thereof
EP1941876A1 (en) * 2006-12-28 2008-07-09 Lacer, S.A. Isosorbide mononitrate derivatives for the treatment of Inflammation and ocular hypertension
US8471041B2 (en) 2010-02-09 2013-06-25 Alliant Techsystems Inc. Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
US8664247B2 (en) 2011-08-26 2014-03-04 Radiorx, Inc. Acyclic organonitro compounds for use in treating cancer
EP2763667B1 (en) 2011-10-07 2022-10-26 EpicentRx, Inc. Organonitro thioether compounds and medical uses thereof
US20140308260A1 (en) 2011-10-07 2014-10-16 Radiorx, Inc. Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
US10342778B1 (en) 2015-10-20 2019-07-09 Epicentrx, Inc. Treatment of brain metastases using organonitro compound combination therapy
US9987270B1 (en) 2015-10-29 2018-06-05 Epicentrix, Inc. Treatment of gliomas using organonitro compound combination therapy
ES2880482T3 (es) 2016-01-11 2021-11-24 Epicentrx Inc Composiciones y métodos para la administración intravenosa de 2-bromo-1-(3,3-dinitroazetidin-1-il)etanona
WO2017137489A1 (en) * 2016-02-12 2017-08-17 Dsm Ip Assets B.V. Anti-methanogenic compositions and uses thereof
AU2017342436C1 (en) 2016-10-14 2022-11-03 Epicentrx, Inc. Sulfoxyalkyl organonitro and related compounds and pharmaceutical compositions for use in medicine
MX2020000265A (es) 2017-07-07 2020-07-22 Epicentrx Inc Composiciones para la administración parenteral de agentes terapéuticos.
WO2019164593A2 (en) 2018-01-08 2019-08-29 Epicentrx, Inc. Methods and compositions utilizing rrx-001 combination therapy for radioprotection
CN110200921B (zh) * 2019-06-19 2020-11-17 华中科技大学 一种具有靶向作用的抗炎脂质体及其制备与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428925A (en) * 1981-12-18 1984-01-31 Key Pharmaceuticals, Inc. Sustained release glycerol trinitrate
DE3728563A1 (de) * 1987-08-27 1989-03-09 Pohl Boskamp Gmbh Chem Pharma N-alkylscopolaminiumsalz und nitroglycerin enthaltendes arzneimittel, verfahren zu dessen herstellung und dessen verwendung
US5004601A (en) * 1988-10-14 1991-04-02 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
WO1993012068A1 (en) * 1991-12-11 1993-06-24 Brigham And Women's Hospital S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
US5632981A (en) * 1992-08-24 1997-05-27 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
ES2179829T3 (es) * 1992-09-18 2003-02-01 Yamanouchi Pharma Co Ltd Preparacion de hidrogel de liberacion prolongada.
JPH06227969A (ja) * 1993-02-02 1994-08-16 Masayasu Sugihara 薬品の腸溶性改善方法およびそれにより得られた薬品組成物
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
DE4420523A1 (de) * 1994-06-13 1995-12-14 Cassella Ag Verwendung von NO-freisetzenden Verbindungen zur Behandlung und Vorbeugung von systemischen Entzündungssyndromen
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system

Also Published As

Publication number Publication date
WO1999016436A1 (en) 1999-04-08
AU9273198A (en) 1999-04-23
EP1019038A1 (en) 2000-07-19
GB9720797D0 (en) 1997-12-03
CA2304516A1 (en) 1999-04-08
JP2001517697A (ja) 2001-10-09

Similar Documents

Publication Publication Date Title
GB9720797D0 (en) Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
HUP0103147A3 (en) Pharmaceutical composition comprising glp1 and their use for the treatment of functional dyspepsia and/or irritable bowel syndrome
IL132145A (en) Compositions for treating inflammatory bowel disease and uses thereof
HK1022835A1 (en) Pharmaceutical composition for treatment of diabetes
ZA987800B (en) Pharmaceutical composition of meloxicam
IL117417A (en) Pharmaceutical composition comprising rapamycin for treating cardiac inflammatory disease and its preparation
ZA987552B (en) Pharmaceutical composition for combination of piperidino-alkanol-decongestant
AU2124397A (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
ID18663A (id) Komposisi farmasi berlapis enterik
PT907364E (pt) Composicao farmaceutica de libertacao sustida
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
HUP0003851A3 (en) Pharmaceutical composition for the treatment or prevention of glomerulopathy
AU2027595A (en) Pharmaceutical composition for treating inflammatory bowel diseases
GB9706842D0 (en) Pharmaceutical compositions for the treatment of rhinitis
HUP0002346A3 (en) Pharmaceutical composition for the treatment of mental illness in mammals
HUP0003244A2 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases and pharmaceutical compositions thereof
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
AU6786898A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU6786598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU8580598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU6786798A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU8049098A (en) Composition and methods for the treatment of inflammatory diseases
AU6786698A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
HUP0000569A3 (en) Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states